Literature DB >> 15474705

Reintroduction of foot-and-mouth disease in Argentina: characterisation of the isolates and development of tools for the control and eradication of the disease.

Nora Mattion1, Guido König, Cristina Seki, Eliana Smitsaart, Eduardo Maradei, Blanca Robiolo, Sergio Duffy, Emilio León, María Piccone, Ana Sadir, Rodolfo Bottini, Bernardo Cosentino, Abraham Falczuk, Ricardo Maresca, Osvaldo Periolo, Rodolfo Bellinzoni, Ana Espinoza, José La Torre, Eduardo L Palma.   

Abstract

This paper describes the antigenic and molecular characterisation of foot-and-mouth disease virus (FMDV) strains isolated during the 2000-2002 epidemic in Argentina, and the strategy implemented for disease control. Two different FMDV serotypes, O and A, were involved. Of the various field isolates studied, two distinct O1 lineages (strains Corrientes/00 and Misiones/00) and two serotype A lineages (A/Argentina/00 and A/Argentina/01 prototypes) were identified. The genome sequences of these strains were compared with sequences of previous regional isolates and sequences of vaccine strains. O1 strains were found to be related to regional strains while serotype A strains were found to be more distanced from them. The updating of the antigenic composition of the vaccines used in the emergency was a key issue, since the outbreaks stopped shortly after the implementation of the vaccination programs. The O1 strains quickly disappeared from the field following strict control measures and the use of vaccines containing O1/Campos strain. However, in the case of the A serotype strains, the situation was different, since the use of a vaccine containing strain A24/Cruzeiro yielded acceptable levels of protection only after re-vaccination. Therefore, the new field strains A/Argentina/00 and A/Argentina/01 were incorporated into the vaccine, leading to an effective control of the disease. Viral circulation greatly diminished, as indicated by the significant reduction in the number of outbreaks and in the number of animals with antibodies against non-structural proteins. Satisfactory levels of protective antibodies were subsequently detected in the cattle population (above 75% protection). The absence of outbreaks after January 2002 indicated that the epidemic was controlled.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15474705     DOI: 10.1016/j.vaccine.2004.06.040

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  16 in total

1.  Evaluation of infectivity and transmission of different Asian foot-and-mouth disease viruses in swine.

Authors:  Juan M Pacheco; P W Mason
Journal:  J Vet Sci       Date:  2010-06       Impact factor: 1.672

2.  Sequence-based prediction for vaccine strain selection and identification of antigenic variability in foot-and-mouth disease virus.

Authors:  Richard Reeve; Belinda Blignaut; Jan J Esterhuysen; Pamela Opperman; Louise Matthews; Elizabeth E Fry; Tjaart A P de Beer; Jacques Theron; Elizabeth Rieder; Wilna Vosloo; Hester G O'Neill; Daniel T Haydon; Francois F Maree
Journal:  PLoS Comput Biol       Date:  2010-12-09       Impact factor: 4.475

3.  Foot-and-mouth disease outbreaks in Egypt during 2013-2014: Molecular characterization of serotypes A, O, and SAT2.

Authors:  Emad Diab; Abdel-Hamid I Bazid; Mohamed Fawzy; Wagdy R El-Ashmawy; Adel A Fayed; Magdy M El-Sayed
Journal:  Vet World       Date:  2019-02-05

4.  A beginner's guide for FMDV quasispecies analysis: sub-consensus variant detection and haplotype reconstruction using next-generation sequencing.

Authors:  Marco Cacciabue; Anabella Currá; Elisa Carrillo; Guido König; María Inés Gismondi
Journal:  Brief Bioinform       Date:  2020-09-25       Impact factor: 11.622

5.  Multiple origins of foot-and-mouth disease virus serotype Asia 1 outbreaks, 2003-2007.

Authors:  Jean Francois Valarcher; Nick J Knowles; Valery Zakharov; Alexey Scherbakov; Zhidong Zhang; You Jun Shang; Zai Xin Liu; Xiang Tao Liu; Aniket Sanyal; Divakar Hemadri; Chakradhar Tosh; Thaha J Rasool; Bramhadev Pattnaik; Kate R Schumann; Tammy R Beckham; Wilai Linchongsubongkoch; Nigel P Ferris; Peter L Roeder; David J Paton
Journal:  Emerg Infect Dis       Date:  2009-07       Impact factor: 6.883

6.  Genetic characterization of foot-and-mouth disease viruses, Ethiopia, 1981-2007.

Authors:  Gelagay Ayelet; Mana Mahapatra; Esayas Gelaye; Berhe G Egziabher; Tesfaye Rufeal; Mesfin Sahle; Nigel P Ferris; Jemma Wadsworth; Geoffrey H Hutchings; Nick J Knowles
Journal:  Emerg Infect Dis       Date:  2009-09       Impact factor: 6.883

7.  Engineering foot-and-mouth disease viruses with improved growth properties for vaccine development.

Authors:  Haixue Zheng; Jianhong Guo; Ye Jin; Fan Yang; Jijun He; Lv Lv; Kesan Zhang; Qiong Wu; Xiangtao Liu; Xuepeng Cai
Journal:  PLoS One       Date:  2013-01-25       Impact factor: 3.240

8.  Transient gene expression in serum-free suspension-growing mammalian cells for the production of foot-and-mouth disease virus empty capsids.

Authors:  Ana Clara Mignaqui; Vanesa Ruiz; Sylvie Perret; Gilles St-Laurent; Parminder Singh Chahal; Julia Transfiguracion; Ayelén Sammarruco; Victoria Gnazzo; Yves Durocher; Andrés Wigdorovitz
Journal:  PLoS One       Date:  2013-08-20       Impact factor: 3.240

9.  Characterization of monoclonal antibodies against foot-and-mouth disease virus serotype O and application in identification of antigenic variation in relation to vaccine strain selection.

Authors:  Ming Yang; Wanhong Xu; Melissa Goolia; Zhidong Zhang
Journal:  Virol J       Date:  2014-08-01       Impact factor: 4.099

10.  Evaluation of Infectivity, Virulence and Transmission of FDMV Field Strains of Serotypes O and A Isolated In 2010 from Outbreaks in the Republic of Korea.

Authors:  Juan M Pacheco; Kwang-Nyeong Lee; Michael Eschbaumer; Elizabeth A Bishop; Ethan J Hartwig; Steven J Pauszek; George R Smoliga; Su-Mi Kim; Jong-Hyeon Park; Young-Joon Ko; Hyang-Sim Lee; Dongseob Tark; In-Soo Cho; Byounghan Kim; Luis L Rodriguez; Jonathan Arzt
Journal:  PLoS One       Date:  2016-01-06       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.